| Name | Title | Contact Details |
|---|
Washington Radiology Assoc is a Sterling, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established in January, 2000, following the consolidation of St. Elizabeth Hospital and Elizabeth General Medical Center, Trinitas Regional Medical Center is a full-service healthcare facility serving those who live and work in Eastern and Central Union County. Operating on two major campuses, Trinitas Regional Medical Center has 554 beds, including a 120-bed long-term care center. Trinitas Regional Medical Center is proud to offer state-of-the-art medicine backed by compassion and competence. Our friendly, professional staff and skilled physicians are the foundation of the care we provide. Together, our medical team offers the community the most advanced technological care in every area of medicine and surgery. Utilizing a full spectrum of sophisticated inpatient, outpatient and long-term care services, Trinitas Regional Medical Center is proud to have forged a lifelong partnership with families, physicians and communities to provide the best care in a supportive and caring environment. We treat over 17,000 inpatients annually, 70,000 emergency patients, and several hundred thousand outpatients. Trinitas Regional Medical Center is pleased to offer a number of Centers of Excellence and specialized major services, including Behavioral Health,Bloodless Medicine, Cancer Care, Cardiology, Diabetes Management,Maternal and Child Health, Renal Services, School of Nursing, Senior Services, Sleep Disorders, Women`s Services, Wound Healing and more. A Catholic teaching hospital, Trinitas Regional Medical Center is sponsored by the Sisters of Charity of Saint Elizabeth in partnership with Elizabethtown Healthcare Foundation.
Massachusetts Hospital Association is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Burlington, MA. To find more information about Massachusetts Hospital Association, please visit www.mhalink.org
lww vision care group is a Ambler, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.